With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Is SIRT5 a Therapy Target in Acute Lymphoblastic Leukemia?||University of Utah / Michael Deininger, MD/PhD||Innovation Grants||2018||Utah|
|Determining Social Risk Factors for Poor Outcomes in Pediatric Cancer Using Children’s Oncology Group Registries||University of Utah / Anne Kirchhoff, PhD/MPH||Epidemiology Grants||2019||Utah|
|Nuclear Receptor Tyrosine Kinases Mediating Chromatin Remodeling & Checkpoint Adaption||Children's Cancer Therapy Development Institute / Charles Keller, MD||Innovation Grants||2018||Oregon|
|A Nurse-Led Structured Discharge Teaching Intervention for Parents of Newly Diagnosed Pediatric Oncology Patients||University of Alabama at Birmingham / Wendy Landier, RN/PhD||Nurse Researcher Grants||2016||Alabama|
|End-of-Life Care of Children with Cancer: Variation and Stakeholder Priorities||University of Alabama at Birmingham / Emily Johnston, MD||Young Investigator Grants||2017||Alabama|
|Investigating the role of BAI1 in the Metastasis of Medulloblastoma||University of Alabama at Birmingham / Satoru Osuka, MD/PhD||Young Investigator Grants||2018||Alabama|
|DNA Methylation Inhibitor Therapy for Testicular Germ Cell Tumors||University of Illinois, Urbana-Champaign / Michael Spinella, Ph.D.||Reach Grants||2014||Illinois|
|Identifying Therapeutic Targets to Prevent Progression of Familial RUNX1 Disorder to AML Using Novel iPSC Models||Icahn School of Medicine at Mount Sinai / Eirini Papapetrou, MD/PhD||Familial RUNX1 Research Grants||2016||New York|
|Modeling the Initiation and Progression of Down Syndrome Associated Leukemia Using CRISPR/Cas9 at Single Cell Resolution||Icahn School of Medicine at Mount Sinai / Elvin Wagenblast, PhD||Young Investigator Grants||2020||New York|
|IND-Enabling Studies for WNTinib, a Novel Selective Therapeutic for CTNNB1 Mutant Hepatoblastomas||Icahn School of Medicine at Mount Sinai / Ernesto Guccione, PhD & Josep Llovet, MD & Arvin Dar, PhD||Reach Grants||2021||New York|